
0:00
53:48
Join Dr Raquel Faria and Professors Richard Furie and Maria Dall’Era as they discuss the results of the phase 3 REGENCY trial of obinutuzumab for the treatment of lupus nephritis.This episode explores what obinutuzumab could mean for the future management of lupus nephritis.
Disclaimer: During Lupus Academy podcast episodes, participants may refer to off label use of medicines forpatients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.
D'autres épisodes de "The Lupus Academy"
Ne ratez aucun épisode de “The Lupus Academy” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.